Showing results (111-120 of 264) with videos related to
Sort By:
Pageof 27
Blood Cancer Discovery|November 15, 2021
Overcoming Acquired Epigenetic Resistance to BTK InhibitorsArthur L Shaffer, James D Phelan, James Q Wang, et al.Cancer Cell|January 12, 2024
Response to Bruton's tyrosine kinase inhibitors in aggressive lymphomas linked to chronic selective autophagyJames D Phelan, Sebastian Scheich, Jaewoo Choi, et al.Blood|May 13, 2004
Fludarabine treatment of patients with chronic lymphocytic leukemia induces a p53-dependent gene expression responseAndreas Rosenwald, Eric Y Chuang, R Eric Davis, et al.Cell Reports|March 10, 2021
Most non-canonical proteins uniquely populate the proteome or immunopeptidomeMaria Virginia Ruiz Cuevas, Marie-Pierre Hardy, Jaroslav Hollý, et al.Journal of Cell Science|August 6, 2009
Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actinGreg P Coffey, Ranjani Rajapaksa, Raymond Liu, et al.Leukemia|May 29, 2024
Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibitionRuiqi Zhu, Courtney M Shirley, S Haihua Chu, et al.BMC Immunology|September 17, 2004
Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organsYulei Shen, Javeed Iqbal, Li Xiao, et al.The New England Journal of Medicine|April 12, 2013
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphomaKieron Dunleavy, Stefania Pittaluga, Lauren S Maeda, et al.Leukemia & Lymphoma|April 15, 2021
Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphomaWyndham H Wilson, Tycel Phillips, Leslie Popplewell, et al.Nature|December 24, 2010
Oncogenically active MYD88 mutations in human lymphomaVu N Ngo, Ryan M Young, Roland Schmitz, et al.Pageof 27